Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Guardant Health United States | 1 | 85 |
|
Guardant Health United States | 1 | 74 |
|
Personalis, Inc. United States | 1 | 413 |
|
Guardant Health United States | 1 | 84 |
|
Hereditary Cancer Screening - Nervous System & Endocrine Cancer Panel (44 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 52 | 44 |
|
Hereditary Cancer Screening - Breast & Gynecological Cancer Panel (33 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 37 | 33 |
|
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 109 | 99 |
|
EZH2 Gene Weaver syndrome NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
EZH2 Gene Leukemia, lymphoblastic and myeloid, EZH2 related NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Tempus Labs, Inc. United States | 2 | 646 |
|
Foundation Medicine, Inc. United States | 2 | 405 |
|
Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 2 | 70 |
|
Weaver syndrome testing (EZH2) Genetic Services Laboratory University of Chicago United States | 1 | 1 |
|
Myeloid Next Generation Sequencing with Reflex Pathology Interp Sentara Healthcare Laboratory Services United States | 3 | 69 |
|
UCSF Molecular Diagnostics Laboratory University of California, San Francisco United States | 1 | 52 |
|
Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 |
|
UCSF Molecular Diagnostics Laboratory UCSF Molecular Diagnostics Laboratory University of California, San Francisco United States | 4 | 52 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 74 | 34 |
|
EZH2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.